Antagonism by salvianolic acid B of lipopolysaccharide-induced disseminated intravascular coagulation in rabbits

Clin Exp Pharmacol Physiol. 2014 Jul;41(7):502-8. doi: 10.1111/1440-1681.12242.

Abstract

The aim of the present study was to investigate the effects of salvianolic acid B on lipopolysaccharide (LPS)-induced disseminated intravascular coagulation (DIC) in rabbits. Continuous infusion of LPS was used to induce a DIC model in rabbits. Treatment with salvianolic acid B (1, 3 or 6 mg/kg) was started simultaneously with LPS infusion (0.5 mg/kg LPS in 60 mL saline; 10 mL/h over a period of 6 h) through the contralateral marginal ear vein. Activated partial thromboplastin time (APTT), prothrombin time (PT), platelet count and fibrinogen concentration were determined, as were plasma levels of fibrin-fibrinogen degradation products (FDP), alanine aminotransferase (ALT), blood urea nitrogen (BUN), protein C activity, antithrombin III (ATIII) and tumour necrosis factor (TNF)-α concentration. The gradual impairment of haemostatic parameters was induced by continuous infusion of LPS. There were marked increases in APTT, PT, BUN, ALT and plasma TNF-α and marked decreases in the platelet count, fibrinogen, FDP, protein C and ATIII. The intravenous administration of 1, 3 or 6 mg/kg salvianolic acid B attenuated the increases in APTT, PT, BUN, ALT and plasma TNF-α and the decreases in fibrinogen, platelet, FDP, protein C and ATIII induced by LPS infusion. These observations indicate that salvianolic acid B has an effect against LPS-induced DIC in rabbits.

Keywords: disseminated intravascular coagulation; heparin; lipopolysaccharide; salvianolic acid B; tumour necrosis factor α.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzofurans / therapeutic use*
  • Disseminated Intravascular Coagulation / chemically induced*
  • Disseminated Intravascular Coagulation / complications
  • Disseminated Intravascular Coagulation / drug therapy*
  • Disseminated Intravascular Coagulation / pathology
  • Gene Expression Regulation / drug effects
  • Kidney Diseases / drug therapy
  • Kidney Diseases / etiology
  • Lipopolysaccharides / toxicity*
  • Liver Diseases / drug therapy
  • Liver Diseases / etiology
  • Male
  • Rabbits
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Benzofurans
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • salvianolic acid B